UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fast Image-Guided Stratification Using Anti-Programmed Death Ligand 1 Gold Nanoparticles for Cancer Immunotherapy

ACS nano, 2017-11, Vol.11 (11), p.11127-11134

2017

Volltextzugriff (PDF)

Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus

Cell reports (Cambridge), 2018-04, Vol.23 (1), p.50-57

2018

Volltextzugriff (PDF)

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications

Scientific reports, 2015-10, Vol.5 (1), p.15400-15400, Article 15400

2015

Volltextzugriff (PDF)

Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma

Haematologica (Roma), 2022-03, Vol.107 (10), p.2395-2407

2022

Volltextzugriff (PDF)

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

Journal for immunotherapy of cancer, 2019-09, Vol.7 (1), p.243-243, Article 243

2019

Volltextzugriff (PDF)

A novel role for an old target: CD45 for breast cancer immunotherapy

Oncoimmunology, 2021-01, Vol.10 (1), p.1929725-1929725

2021

Volltextzugriff (PDF)

Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes

Journal of Immunology, 2006-11, Vol.177 (9), p.6548-6559

2006

Volltextzugriff (PDF)

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor

Frontiers in immunology, 2017-09, Vol.8, p.1212-1212

2017

Volltextzugriff (PDF)

Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles

ACS omega, 2021-11, Vol.6 (43), p.28507-28514

2021

Volltextzugriff (PDF)

Genetically engineering glycolysis in T cells increases their antitumor function

Journal for immunotherapy of cancer, 2024-07, Vol.12 (7), p.e008434

2024

Volltextzugriff (PDF)

TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection

Nature (London), 2019-07, Vol.571 (7764), p.265-269

2019

Volltextzugriff (PDF)

The mutational status of p53 can influence its recognition by human T-cells

Oncoimmunology, 2017-04, Vol.6 (4), p.e1285990-e1285990

2017

Volltextzugriff (PDF)

Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T‑Cells in Vivo with Gold Nanoparticles and CT Imaging

ACS nano, 2015-06, Vol.9 (6), p.6363-6372

2015

Volltextzugriff (PDF)

Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides

Journal for immunotherapy of cancer, 2019-05, Vol.7 (1), p.135-9, Article 135

2019

Volltextzugriff (PDF)

Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide

Frontiers in medicine, 2021-08, Vol.8, p.675963-675963

2021

Volltextzugriff (PDF)

Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity

The Journal of immunology (1950), 2013-10, Vol.191 (8), p.4121-4129

2013

Volltextzugriff (PDF)

Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells

Molecular carcinogenesis, 2020-07, Vol.59 (7), p.713-723

2020

Volltextzugriff (PDF)

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

The Journal of clinical investigation, 2015-10, Vol.125 (10), p.3981-3991

2015

Volltextzugriff (PDF)

T-cells “à la CAR-T(e)” – Genetically engineering T-cell response against cancer

Advanced drug delivery reviews, 2019-02, Vol.141, p.23-40

2019

Volltextzugriff (PDF)

Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis

Clinical cancer research, 2022-12, Vol.28 (23), p.5156-5166

2022

Volltextzugriff (PDF)

Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells

The Journal of immunology (1950), 2012-02, Vol.188 (4), p.1708-1716

2012

Volltextzugriff (PDF)

Human gamma delta T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells

The Journal of immunology (1950), 2012-02, Vol.188 (4), p.1708-1716

2012

Volltextzugriff (PDF)

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

Cancer research (Chicago, Ill.), 2006-09, Vol.66 (17), p.8878-8886

2006

Volltextzugriff (PDF)

Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity

The Journal of immunology (1950), 2012-06, Vol.188 (11), p.5538-5546

2012

Volltextzugriff (PDF)

Multifunctional nanoprobe for real-time in vivo monitoring of T cell activation

Nanomedicine, 2022-11, Vol.46, p.102596-102596, Article 102596

2022

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(44)
Humans
(35)
Immunology
(21)
Oncology
(21)
Animals
(19)
Immunotherapy
(19)
Mice
(17)
T-Lymphocytes - Immunology
(15)
Antigens
(13)
Lymphocytes
(13)
Receptors, Antigen, T-Cell - Genetics
(13)
Tumors
(13)
Melanoma
(12)
Cell Line, Tumor
(11)
Medical Sciences
(11)
Biological And Medical Sciences
(10)
Cancer
(10)
Melanoma - Immunology
(9)
T Cell Receptors
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Fast Image-Guided Stratification Using Anti-Programmed Death Ligand 1 Gold Nanoparticles for Cancer Immunotherapy

Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications

Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

A novel role for an old target: CD45 for breast cancer immunotherapy

Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor

Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles

Genetically engineering glycolysis in T cells increases their antitumor function

TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection

The mutational status of p53 can influence its recognition by human T-cells

Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T‑Cells in Vivo with Gold Nanoparticles and CT Imaging

Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides

Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide

Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity

Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

T-cells “à la CAR-T(e)” – Genetically engineering T-cell response against cancer

Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis

Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells

Human gamma delta T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity

Multifunctional nanoprobe for real-time in vivo monitoring of T cell activation

Suchergebnisse filtern